tiprankstipranks
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
Holding CSBR?
Track your performance easily

Champions Oncology (CSBR) Technical Analysis

121 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Champions Oncology Inc’s (CSBR) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Champions Oncology Inc is a Sell.
Champions Oncology Inc’s (CSBR) 20-Day exponential moving average is 4.38, while Champions Oncology Inc’s (CSBR) share price is $4.27, making it a Sell.
Champions Oncology Inc’s (CSBR) 50-Day exponential moving average is 4.42, while Champions Oncology Inc’s (CSBR) share price is $4.27, making it a Sell.

Champions Oncology (CSBR) Pivot Points

Nov 22, 2024, 03:33 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.79
4.03
4.17
4.41
4.55
4.79
4.93
Fibonacci
4.03
4.17
4.26
4.41
4.55
4.64
4.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Champions Oncology (CSBR) Moving Averages

Nov 22, 2024, 03:33 AM
Period
Simple
Exponential
MA5
4.43Sell
4.39Sell
MA10
4.48Sell
4.40Sell
MA20
4.27Sell
4.38Sell
MA50
4.47Sell
4.42Sell
MA100
4.56Sell
4.56Sell
MA200
4.85Sell
4.87Sell
Champions Oncology Inc’s (CSBR) 10-Day exponential moving average is 4.40, while Champions Oncology Inc’s (CSBR) share price is $4.27, making it a Sell.
Champions Oncology Inc’s (CSBR) 100-Day exponential moving average is 4.56, while Champions Oncology Inc’s (CSBR) share price is $4.27, making it a Sell.
Champions Oncology Inc’s (CSBR) stock price is $4.27 and Champions Oncology Inc’s (CSBR) 50-day simple moving average is 4.47, creating a Sell signal.
Champions Oncology Inc’s (CSBR) stock price is $4.27 and Champions Oncology Inc’s (CSBR) 100-day simple moving average is 4.56, creating a Sell signal.
Champions Oncology Inc’s (CSBR) stock price is $4.27 and Champions Oncology Inc’s (CSBR) 200-day simple moving average is 4.85, creating a Sell signal.

Champions Oncology (CSBR) Technical Indicators

Nov 22, 2024, 03:33 AM
Name
Value
Implied Action
RSI (14)
46.22
Neutral
STOCH (9,6)
27.27
Neutral
STOCHRSI (14)
61.58
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
15.89
Buy
Williams %R
-57.72
Buy
CCI (14)
35.46
Neutral
ATR (14)
0.28
-
Ultimate Oscillator
34.33
Neutral
ROC
6.75
Buy
Champions Oncology Inc’s (CSBR) Relative Strength Index (RSI) is 46.22, creating a Neutral signal.
Champions Oncology Inc’s (CSBR) Trend Strength Indicator (ADX) is 15.89, creating a Buy signal.
Champions Oncology Inc’s (CSBR) Commodity Channel Index (CCI) is 35.46, creating a Neutral signal.
Champions Oncology Inc’s (CSBR) Price Rate of Change (ROC) is 6.75, creating a Buy signal.

FAQ

Is CSBR a Buy, Hold, or Sell?
Based on CSBR’s technical indicators, CSBR is a Sell.
    What is CSBR’s RSI (14)?
    CSBR’s RSI (14) is 46.22, which suggests CSBR is a Neutral.
      What is CSBR’s MACD?
      CSBR’s MACD is 0.02, which suggests CSBR is a Sell.
        What is CSBR’s 5-day moving average?
        CSBR’s 5-day moving average is 4.43, which suggests CSBR is a Sell.
          What is CSBR’s 20-day moving average?
          CSBR 20-day moving average is 4.27, which suggests CSBR is a Sell.
            What is CSBR’s 50-day moving average?
            CSBR’s 50-day moving average is 4.47, which suggests CSBR is a Sell.
              What is CSBR’s 200-day moving average?
              CSBR’s 200-day moving average is 4.85, which suggests CSBR is a Sell.
                What is CSBR’s Williams % R (14)?
                CSBR’s Williams % R (14) is -57.72, which suggests CSBR is a Buy.
                  What is CSBR’s CCI (14)?
                  CSBR’s CCI (14) is 35.46, which suggests CSBR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis